SC
ABBV icon

Stolper & Co’s AbbVie ABBV Stock Holding History

Stolper & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Buy
15,019
+413
+3% +$88.9K 0.98% 32
2026
Q1 		$3.18M Sell
14,606
-99
-0.7% -$22K 0.9% 36
2025
Q4 		$3.36M Sell
14,705
-8
-0.1% -$1.82K 0.99% 30
2025
Q3 		$3.41M Buy
14,713
+449
+3% +$91.4K 1.03% 32
2025
Q2 		$2.65M Sell
14,264
-46
-0.3% -$8.55K 0.87% 33
2025
Q1 		$3M Sell
14,310
-196
-1% -$38.1K 0.98% 31
2024
Q4 		$2.58M Buy
14,506
+68
+0.5% +$12.5K 0.86% 33
2024
Q3 		$2.85M Sell
14,438
-64
-0.4% -$11.9K 0.93% 31
2024
Q2 		$2.49M Sell
14,502
-32
-0.2% -$5.3K 0.88% 32
2024
Q1 		$2.65M Buy
14,534
+19
+0.1% +$3.27K 0.95% 32
2023
Q4 		$2.25M Sell
14,515
-216
-1% -$31.5K 0.91% 31
2023
Q3 		$2.2M Sell
14,731
-123
-0.8% -$18.1K 0.95% 32
2023
Q2 		$2M Sell
14,854
-128
-0.9% -$18.8K 0.84% 34
2023
Q1 		$2.39M Sell
14,982
-98
-0.6% -$15K 1.02% 31
2022
Q4 		$2.44M Sell
15,080
-3,469
-19% -$532K 1.07% 30
2022
Q3 		$2.49M Buy
18,549
+927
+5% +$133K 1.23% 29
2022
Q2 		$2.7M Sell
17,622
-710
-4% -$108K 1.27% 27
2022
Q1 		$2.97M Buy
18,332
+350
+2% +$50.8K 1.26% 26
2021
Q4 		$2.44M Buy
17,982
+5
+0% +$591 1.09% 29
2021
Q3 		$1.94M Buy
17,977
+197
+1% +$22.5K 0.93% 34
2021
Q2 		$2M Buy
17,780
+112
+0.6% +$12.6K 0.94% 31
2021
Q1 		$1.91M Sell
17,668
-171
-1% -$18.3K 0.98% 30
2020
Q4 		$1.91M Buy
17,839
+273
+2% +$26.2K 1.07% 29
2020
Q3 		$1.54M Sell
17,566
-3,044
-15% -$287K 0.99% 32
2020
Q2 		$2.02M Sell
20,610
-1,549
-7% -$136K 1.32% 27
2020
Q1 		$1.69M Buy
+22,159
New +$1.89M 1.21% 29

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Stolper & Co's ABBV Position: Q2 2026 in Review

Stolper & Co increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $88.9K and bringing the position to 15,019 shares worth $3.78M. The position accounts for 0.98% of the portfolio, ranked #32.

Stolper & Co first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 971 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Stolper & Co held 15,019 shares of AbbVie worth $3.78M as of Q2 2026.
  • Stolper & Co bought 413 AbbVie shares in Q2 2026, an estimated $88.9K.
  • AbbVie made up 0.98% of Stolper & Co's portfolio in Q2 2026, its #32 holding.
  • Stolper & Co first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 971 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stolper & Co's 13F filing for Q2 2026, filed 14 Jul 2026.